ImmunoBlue
1 known investors
ImmunoBlue develops nanoimmunotherapies that combine nanotechnology with immunotherapy approaches to treat cancer.
BiotechDeep TechMedical Devices
Investors · 1
In the news
- ImmunoBlue - 2025 Company Profile, Funding & Competitors - Tracxntracxn.com · 2025